Healthy volunteers needed to test new drug absorption
NCT ID NCT07545590
First seen May 02, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This study looks at how a new drug called eltrekibart is absorbed when injected under the skin. It involves 60 healthy adults who will receive a single dose and be monitored for about 17 weeks. The goal is to measure drug levels in the blood and check for side effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lilly Centre for Clinical Pharmacology
Singapore, 138623, Singapore
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.